JOURNAL OF CHEMICAL RESEARCH 2014 83
CDCl3) 7.42 (1H, dd, 3J=8.0 Hz, 3J=8.0 Hz), 7.54–7.59 (2H, m), 7.63 (dd,
4J=2.0 Hz, 4J= 1.6 H z); δC (100.5 MHz, CDCl3) 113.9 (Cquat), 117.4 (Cquat),
130.3 (CH), 130.5 (CH), 131.9 (CH), 133.2 (CH), 135.2 (Cquat); MS (EI,
70 eV) m/z (%) 139 (37ClM+, 32), 137 (35ClM+, 100).
OCH2), 6.95–6.99 (2H, m), 7.50–7.55 (3H, m); δC (100.5 MHz, CDCl3)
14.7 (CH3), 64.5 (OCH2), 101.8 (Cquat), 112.3 (CH), 116.5 (Cquat), 120.7
(CH), 133.7 (CH), 134.4 (CH), 160.7 (Cquat); MS (EI, 70 eV) m/z (%) 147
(M+, 100).
3,4-Dimethoxybenzonitrile (2q); typical procedure B to prepare
benzonitriles from benzaldoximes: BrCCl3 (940 mg, 4.8 mmol) was
added to PPh3 (1.26 g, 4.8 mmol) in dry CH2Cl2 (14 mL). The resulting
mixture was stirred at room temperature for 20 min, during which time
the solution turned from yellow to red–brownish in colour. Thereafter,
3,4-dimethoxybenzaldoxime (4i, 800 mg, 4.4 mmol) was added. The
reaction mixture was heated under reflux for 25 min. Then, dry Et3N
(485 mg, 4.8 mmol) was added dropwise with a syringe over 1 min.
The reaction mixture was heated under reflux for 8 h. Thereafter, it
was cooled to room temperature and added to cold water (50 mL).
The mixture was extracted with dichloromethane (2×30 mL) and
chloroform (30 mL). The combined organic phases were dried over
anhydrous MgSO4, concentrated under reduced pressure and subjected
to column chromatography on silica gel (CH2Cl2/hexane 4:1) to give
3,4-dimethoxybenzonitrile (2q, 665 mg, 92%) as a colourless solid; m.p.
69–70 °C (lit.29 68–70 °C); vmax (KBr/cm–1) 3085, 3001, 2838, 2224 (CN),
1598, 1583, 1413, 1335, 1271, 1246, 1138, 1018, 929, 877, 812, 766, 617; δH
(400 MHz, CDCl3) 3.89 (3H, s, OCH3), 3.92 (3H, s, OCH3), 6.90 (1H, d,
3J=8.4 Hz), 7.11 (1H, s), 7.29 (1H, d, 3J= 8.4 H z); δC (100.5 MHz, CDCl3)
56.0 (OCH3), 56.1 (OCH3), 103.9 (CN), 111.2 (CH), 113.9 (CH), 119.2
(Cquat), 126.5 (CH), 149.1 (Cquat), 152.8 (Cquat); MS (EI, 70 eV) m/z (%) 163
(M+, 100), 120 (21), 77 (21).
2-Propoxybenzonitrile (2c, procedure A): Colourless oil; vmax (KBr/cm–1)
3079, 2968, 2880, 2227 (CN), 1597, 1489, 1393, 1261, 1166, 1113, 1062,
974, 838, 754, 499; δH (400 MHz, CDCl3) 1.06 (3H, t, 3J=7.6 Hz, CH3),
3
3
3
1.87 (2H, dt, J=7.6 Hz, J=6.4 Hz), 4.02 (2H, t, J=6.4 Hz, OCH2),
6.94–6.96 (3H, m), 7.47–7.54 (2H, m); δC (100.5 MHz, CDCl3) 10.4 (CH3),
22.3 (CH2), 70.4 (OCH2), 101.9 (CN, Cquat), 112.2 (CH), 116.6 (Cquat), 120.5
(CH), 133.7 (CH), 134.3 (CH), 160.8 (Cquat). Anal. calcd for C10H11NO
(161.20): C, 74.51; H, 6.88; N, 8.69; found: C, 74.32; H, 6.95; N, 8.26%.
2-Butoxybenzonitrile (2d, procedure A): Colourless oil; vmax (KBr/cm–1)
2872, 2226 (CN), 1601, 1581, 1497, 1250, 1166, 1109, 1064, 969, 747; δH
(400 MHz, CDCl3) 0.97 (3H, t, 3J=7.0 Hz, CH3), 1.48–1.57 (2H, m), 1.79–
1.86 (2H, m), 4.06 (2H, t, 3J=6.4 Hz, OCH2), 6.93–6.99 (3H, m), 7.47–
7.54 (2H, m); δC (100.5 MHz, CDCl3) 13.8 (CH3), 19.1 (CH2), 30.9 (CH2),
68.7 (OCH2), 101.9 (CN, Cquat), 112.1 (CH), 116.6 (Cquat), 120.5 (CH), 133.8
(CH), 134.3 (CH), 160.8 (Cquat). Anal. calcd for C11H13NO (175.22): C,
75.40; H, 7.48; N 7.99; found: C, 75.25; H, 7.52; N, 7.27%.
2-Pentoxybenzonitrile (2e, procedure A): Colourless oil; vmax (KBr/
cm–1) 2957, 2873, 2227 (CN), 1598, 1493, 1451, 1290, 1260, 1165, 1110,
756; δH (400 MHz, CDCl3) 0.92 (3H, t, 3J=7.2 Hz, CH3), 1.33–1.44 (2H,
m), 1.44–1.50 (2H, m), 1.80–1.87 (2H, m), 4.05 (2H, t, 3J=6.4 Hz, OCH2),
6.92–6.97 (2H, m), 7.47–7.54 (2H, m); δC (100.5 MHz, CDCl3) 14.0 (CH3),
22.4 (CH2), 28.0 (CH2), 28.6 (CH2), 69.0 (OCH2), 101.9 (Cquat), 112.1 (CH),
116.6 (Cquat), 120.5 (CH), 133.8 (CH), 134.3 (CH), 160.8 (Cquat). Anal.
calcd for C12H15NO (189.25): C, 76.16; H, 7.99; N, 7.40; found: C, 76.29;
H, 8.09; N, 6.86%.
2-Octoxybenzonitrile (2f, procedure A): Colourless oil; vmax (KBr/cm–1)
3079, 2928, 2856, 2228 (CN), 1598, 1494, 1451, 1289, 1261, 1165, 1110,
1043, 756; δH (400 MHz, CDCl3) 0.87 (3H, t, 3J=6.4 Hz, CH3), 1.27–1.31
(8H, m), 1.46–1.48 (2H, m), 1.82–1.85 (2H, m), 4.05 (2H, t, 3J=6.4 Hz,
OCH2), 6.92–6.96 (2H, m), 7.49–7.54 (2H, m); δC (100.5 MHz, CDCl3)
14.1 (CH3), 22.7 (CH2), 25.9 (CH2), 28.9 (CH2), 29.2 (CH2), 29.3 (CH2),
31.8 (CH2), 69.0 (OCH2), 101.9 (Cquat), 112.1 (CH), 116.6 (Cquat), 120.5
(CH), 133.8 (CH), 134.3 (CH), 160.8 (Cquat). Anal. calcd for C15H21NO
(231.33): C, 77.88; H, 9.15; N, 6.05; found: C, 77.92; H, 9.18; N, 5.53%.
2-Allyloxybenzonitrile (2g, procedure A): Colourless oil; vmax (KBr/cm–1)
3082, 3023, 2990, 2927, 2873, 2227 (CN), 1599, 1580, 1492, 1450, 1425,
1290, 1270, 1235, 1166, 1111, 1044, 995, 934, 839, 755, 497; δH (400 MHz,
CDCl3) 4.64–4.66 (2H, m, OCH2). 5.30–5.34 (1H, m), 5.44–5.49 (1H, m),
5.98–6.08 (1H, m), 6.93–7.01 (2H, m), 7.47–7.56 (2H, m); δC (100.5 MHz,
CDCl3) 69.4 (OCH2), 102.1 (Cquat), 112.6 (CH), 116.5 (Cquat), 118.3 (CH2),
120.9 (CH), 131.8 (CH), 133.8 (CH), 134.2 (CH), 160.2 (Cquat); Anal. calcd
for C10H9NO (159.18): C, 75.45%; H, 5.70; N, 8.80; found: 75.42%; H,
5.85%; N, 8.67%.
Benzonitrile30 (2h, procedure A): Colourless oil; vmax (neat/cm–1) 2232
(CN), 1598, 1495, 1450, 772, 691, 650; δH (400 MHz, CDCl3) 7.46 (2H, dd,
3J=7.6 Hz, 3J=7.6 Hz), 7.60 (1H, dd, 3J=7.6 Hz, 3J=7.6 Hz), 7.64 (2H, d,
3J=7.6 Hz); δC (100.5 MHz, CDCl3) 112.4 (Cquat), 118.9 (Cquat), 129.1 (2C,
CH), 132.2 (2C, CH), 132.8 (CH); MS (EI, 70 eV) m/z (%) 103 (M+, 100),
76 (34).
4-Tolunitrile30 (2k, procedure B): Colourless oil; vmax (neat/cm–1) 2925,
2228 (CN), 1608, 1508, 817, 546; δH (400 MHz, CDCl3) 2.40 (3H, s, CH3),
7.25 (2H, d, 3J=7.6 Hz), 7.52 (2H, d, 3J= 7.6 H z); δC (100.5 MHz, CDCl3)
21.8 (CH3), 109.2 (Cquat), 119.2 (Cquat), 129.8 (2C, CH), 132.0 (2C, CH),
143.7 (Cquat); MS (EI, 70 eV) m/z (%) 117 (M+, 100), 90 (25).
4–Ethoxybenzonitrile (2v); typical procedure
C to prepare
benzonitriles from benzaldoximes with CBrCl3 and 2 equiv. PPh3:
BrCCl3 (650 mg, 3.3 mmol) was added to PPh3 (870 mg, 3.3 mmol) in dry
CH2Cl2 (10 mL). The resulting mixture was stirred at room temperature
for 20 min, during which time the solution turned from yellow to red–
brownish in colour. Thereafter, 4-ethoxybenzaldoxime (4n, 500 mg,
3.05 mmol) was added. The reaction mixture was heated under reflux
for 25 min. Then, triphenylphosphine (870 mg, 3.3 mmol) was added,
and the mixture was stirred for 8 h at reflux. The cooled reaction mixture
was concentrated under reduced pressure and subjected directly to
column chromatography on silica gel (CH2Cl2–hexane 5:1) to give 2v
as a colourless solid (404 mg, 90%); m.p. 64 °C (lit.29 62–64 °C); vmax
(KBr/cm–1) 2218 (CN), 1611, 1511, 1398, 1303, 1172, 1039, 844, 808,
706, 547; δH (400 MHz, CDCl3) 1.41 (3H, t, 3J=7.2 Hz, CH3), 4.05 (2H,
q, 3J=7.2 Hz, OCH2), 6.90 (2H, d, 3J=7.6 Hz), 7.54 (2H, d, 3J=7.6 Hz);
δC (100.5 MHz, CDCl3) 14.5 (CH3), 63.9 (OCH2), 103.6 (Cquat), 115.1 (2C,
CH), 119.3 (Cquat), 133.9 (2C, CH), 162.2 (Cquat); MS (EI, 70 eV) m/z (%)
147 (M+, 27), 119 (100).
4-Nitrobenzonitrile (2j); typical procedure D to prepare benzonitriles
from benzamides with CBrCl3 and 2 equiv. PPh3: BrCCl3 (230 mg,
1.15 mmol) was added to PPh3 (290 mg, 1.1 mmol) in dry CH2Cl2 (8 mL).
The resulting mixture was stirred at room temperature for 20 min,
during which time the solution turned from yellow to red–brownish
in colour. Thereafter, 4-nitrobenzamide (4n, 143 mg, 0.95 mmol) was
added. The reaction mixture was heated under reflux for 25 min. Then,
PPh3 (290 mg, 1.1 mmol) was added, and the mixture was stirred for 7 h
at reflux. The cooled reaction mixture was concentrated under reduced
pressure and subjected directly to column chromatography on silica
gel (CH2Cl2) to give 2j (130 mg, 92%) as a colourless solid, m.p. 149–
150 °C (lit.29 144–147 °C); vmax (KBr/cm–1) 2233 (CN), 1603, 1526, 1488,
1349, 1295, 1015, 860, 748, 683, 540; δH (400 MHz, CDCl3) 7.83 (2H, d,
3J=8.8 Hz), 8.30 (2H, d, 3J= 8.8 H z); δC (100.5 MHz, CDCl3) 115.8 (Cquat),
117.3 (Cquat), 123.3 (2C, CH), 132.5 (2C, CH), 149.0 (Cquat); MS (EI, 70 eV)
m/z (%) 148 (M+, 34), 102 (100).
3-Bromobenzonitrile (2L, procedure B): Pale yellow solid; m.p. 39–
40 °C (lit.29 38–40 °C); vmax (KBr/cm–1) 2231 (CN), 1560, 1478, 1408,
1189, 1076, 997, 913, 893, 783, 675, 439; δH (400 MHz, CDCl3) 7.35 (1H,
2-Methoxybenzonitrile30 (2a, procedure A): Colourless oil: vmax (KBr/cm–1)
3020, 2950, 2840, 2230 (CN), 1600, 1495, 1465, 1440, 1290, 1260, 1115,
1020, 760; δH (400 MHz, CDCl3) 3.92 (3H, s, OCH3), 6.98–7.02 (2H, m),
7.55–7.58 (3H, m); δC (100.5 MHz, CDCl3) 56.1 (OCH3), 101.6 (Cquat),
111.7 (CH), 116.6 (Cquat), 121.0 (CH), 133.8 (CH), 134.9 (CH), 162.3 (Cquat);
MS (EI, 70 eV) m/z (%) 133 (M+, 100), 104 (65), 90 (43).
3
3
3
dd, J=8.0 Hz, J=8.0 Hz), 7.59 (1H, dm, J=8.0 Hz), 7.73 (1H, dm,
3J=8.0 Hz), 7.78 (1H, bs); δC (100.5 MHz, CDCl3) 114.2 (Cquat), 117.3
(Cquat), 122.9 (Cquat), 130.6 (CH), 130.7 (CH), 134.8 (CH), 136.1 (CH); MS
(EI, 70 eV) m/z (%) 183 (81BrM+, 85), 181 (79BrM+, 87), 102 (100).
3-Fluorobenzonitrile30 (2m, procedure B): A colourless oil; vmax
(neat/cm–1) 3078, 2235 (CN), 1585, 1483, 1434, 1252, 1127, 929, 875,
793, 676; δH (400 MHz, CDCl3) 7.24–7.31 (2H, m), 7.40–7.42 (2H, m); δC
2–Ethoxybenzonitrile30 (2b, procedure A): Colourless oil; δH
(400 MHz, CDCl3) 1.47 (3H, t, 3J=7.0 Hz, CH3), 4.15 (2H, q, 3J=7.0 Hz,
PRK1302181_FINAL.indd 83
30/01/2014 11:35:30